Items where the Publication is European journal of heart failure

Year Authors/Creators Item Type Full Text

Bibliographic data only

Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. (2009) Allen, Larry A; Felker, G Michael; Pocock, Stuart; McMurray, John JV; Pfeffer, Marc A; Swedberg, Karl; Wang, Duolao; Yusuf, Salim; Michelson, Eric L; Granger, Christopher B; CHARM Investigators

Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF). (2015) Cannon, Jane A; Collier, Timothy J; Shen, Li; Swedberg, Karl; Krum, Henry; Van Veldhuisen, Dirk J; Vincent, John; Pocock, Stuart J; Pitt, Bertram; Zannad, Faiez; McMurray, John JV

Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study. (2016) Chin, Ken Lee; Collier, Timothy J; Pitt, Bertram; McMurray, John JV; Swedberg, Karl; van Veldhuisen, Dirk J; Pocock, Stuart J; Vincent, John; Turgonyi, Eva; Zannad, Faiez; Krum, Henry; EMPHASIS-HF Study Investigators

Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis. (2010) Davies, Edward J; Moxham, Tiffany; Rees, Karen; Singh, Sally; Coats, Andrew JS; Ebrahim, Shah; Lough, Fiona; Taylor, Rod S

Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme. (2007) Hawkins, Nathaniel M; Wang, Duolao; McMurray, John JV; Pfeffer, Marc A; Swedberg, Karl; Granger, Christopher B; Yusuf, Salim; Pocock, Stuart J; Ostergren, Jan; Michelson, Eric L; Dunn, Francis G; CHARM Investigators and Committees

Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme. (2010) Hawkins, Nathaniel M; Wang, Duolao; Petrie, Mark C; Pfeffer, Marc A; Swedberg, Karl; Granger, Christopher B; Yusuf, Salim; Solomon, Scott D; Ostergren, Jan; Michelson, Eric L; Pocock, Stuart J; Maggioni, Aldo P; McMurray, John JV; CHARM Investigators and Committees

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). (2012) Preiss, David; van Veldhuisen, Dirk J; Sattar, Naveed; Krum, Henry; Swedberg, Karl; Shi, Harry; Vincent, John; Pocock, Stuart J; Pitt, Bertram; Zannad, Faiez; McMurray, John JV

A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy. (2002) Rogers, Angie; Addington-Hall, Julia M; McCoy, Anne SM; Edmonds, Polly M; Abery, Alison J; Coats, Andrew JS; Gibbs, J Simon R

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. (2013) Rogers, Jennifer K; Pocock, Stuart J; McMurray, John JV; Granger, Christopher B; Michelson, Eric L; Östergren, Jan; Pfeffer, Marc A; Solomon, Scott D; Swedberg, Karl; Yusuf, Salim

Comment on "Hospital admission following a diagnosis of heart failure: is time to first admission telling us what we want to know?" - Reply to comment. (2002) Shibata, MC; Flather, M; Wang, DL

Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. (2001) Shibata, MC; Flather, MD; Wang, D

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. (2013) Zannad, Faiez; Garcia, Angeles Alonso; Anker, Stefan D; Armstrong, Paul W; Calvo, Gonzalo; Cleland, John GF; Cohn, Jay N; Dickstein, Kenneth; Domanski, Michael J; Ekman, Inger; Filippatos, Gerasimos S; Gheorghiade, Mihai; Hernandez, Adrian F; Jaarsma, Tiny; Koglin, Joerg; Konstam, Marvin; Kupfer, Stuart; Maggioni, Aldo P; Mebazaa, Alexandre; Metra, Marco; Nowack, Christina; Pieske, Burkert; Piña, Ileana L; Pocock, Stuart J; Ponikowski, Piotr; Rosano, Giuseppe; Ruilope, Luis M; Ruschitzka, Frank; Severin, Thomas; Solomon, Scott; Stein, Kenneth; Stockbridge, Norman L; Stough, Wendy Gattis; Swedberg, Karl; Tavazzi, Luigi; Voors, Adriaan A; Wasserman, Scott M; Woehrle, Holger; Zalewski, Andrew; McMurray, John JV

Public

Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial. (2019) Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos S; Jamal, Waheed; Salsali, Afshin; Schnee, Janet; Kimura, Karen; Zeller, Cordula; George, Jyothis; Brueckmann, Martina; Zannad, Faiez; Packer, Milton; EMPEROR-Preserved Trial Committees and Investigators

Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial. (2020) Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Shahzeb Khan, Muhammad; Ferreira, João Pedro; Bocchi, Edimar; Böhm, Michael; Brunner-La Rocca, Hans Pieter; Choi, Dong-Ju; Chopra, Vijay; Chuquiure, Eduardo; Giannetti, Nadia; Gomez-Mesa, Juan Esteban; Janssens, Stefan; Januzzi, James L; Gonzalez-Juanatey, Jose R; Merkely, Bela; Nicholls, Stephen J; Perrone, Sergio V; Piña, Ileana L; Ponikowski, Piotr; Senni, Michele; Seronde, Marie-France; Sim, David; Spinar, Jindrich; Squire, Iain; Taddei, Stefano; Tsutsui, Hiroyuki; Verma, Subodh; Vinereanu, Dragos; Zhang, Jian; Jamal, Waheed; Schnaidt, Sven; Schnee, Janet M; Brueckmann, Martina; Pocock, Stuart J; Zannad, Faiez; Packer, Milton; EMPEROR-Preserved Trial Committees and Investigators

Rationale and design of Ferinject assessment in patients with IRon deficiency and chronic Heart Failure (FAIR-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. (2009) Anker, Stefan D; Colet, Josep Comin; Filippatos, Gerasimos; Willenheimer, Ronnie; Dickstein, Kenneth; Drexler, Helmut; Lüscher, Thomas F; Mori, Claudio; von Eisenhart Rothe, Barbara; Pocock, Stuart; Poole-Wilson, Philip A; Ponikowski, Piotr; FAIR-HF committees and investigators picture_as_pdf

Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis. (2017) Anker, Stefan D; Kirwan, Bridget-Anne; van Veldhuisen, Dirk J; Filippatos, Gerasimos; Comin-Colet, Josep; Ruschitzka, Frank; Lüscher, Thomas F; Arutyunov, Gregory P; Motro, Michael; Mori, Claudio; Roubert, Bernard; Pocock, Stuart J; Ponikowski, Piotr

The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors. (2017) Butler, Javed; Hamo, Carine E; Filippatos, Gerasimos; Pocock, Stuart J; Bernstein, Richard A; Brueckmann, Martina; Cheung, Alfred K; George, Jyothis T; Green, Jennifer B; Januzzi, James L; Kaul, Sanjay; Lam, Carolyn SP; Lip, Gregory YH; Marx, Nikolaus; McCullough, Peter A; Mehta, Cyrus R; Ponikowski, Piotr; Rosenstock, Julio; Sattar, Naveed; Salsali, Afshin; Scirica, Benjamin M; Shah, Sanjiv J; Tsutsui, Hiroyuki; Verma, Subodh; Wanner, Christoph; Woerle, Hans-Juergan; Zannad, Faiez; Anker, Stefan D; EMPEROR Trials Program

New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment. (2017) Cowie, Martin R; Filippatos, Gerasimos S; Alonso Garcia, Maria de Los Angeles; Anker, Stefan D; Baczynska, Anna; Bloomfield, Daniel M; Borentain, Maria; Bruins Slot, Karsten; Cronin, Maureen; Doevendans, Pieter A; El-Gazayerly, Amany; Gimpelewicz, Claudio; Honarpour, Narimon; Janmohamed, Salim; Janssen, Heidi; Kim, Albert M; Lautsch, Dominik; Laws, Ian; Lefkowitz, Martin; Lopez-Sendon, Jose; Lyon, Alexander R; Malik, Fady I; McMurray, John JV; Metra, Marco; Figueroa Perez, Santiago; Pfeffer, Marc A; Pocock, Stuart J; Ponikowski, Piotr; Prasad, Krishna; Richard-Lordereau, Isabelle; Roessig, Lothar; Rosano, Giuseppe MC; Sherman, Warren; Stough, Wendy Gattis; Swedberg, Karl; Tyl, Benoit; Zannad, Faiez; Boulton, Caroline; De Graeff, Pieter

Telemedicine in heart failure: new insights from the Cochrane meta-analyses. (2016) Dierckx, Riet; Inglis, Sally C; Clark, Robyn A; Prieto-Merino, David; Cleland, John GF

Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study. (2018) Ferreira, João Pedro; Metra, Marco; Mordi, Ify; Gregson, John; Ter Maaten, Jozine M; Tromp, Jasper; Anker, Stefan D; Dickstein, Kenneth; Hillege, Hans L; Ng, Leong L; van Veldhuisen, Dirk J; Lang, Chim C; Voors, Adriaan A; Zannad, Faiez

Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial. (2022) Ferreira, João Pedro; Verdonschot, Job AJ; Girerd, Nicolas; Bozec, Erwan; Pellicori, Pierpaolo; Collier, Timothy; Mariottoni, Beatrice; Cosmi, Franco; Hazebroek, Mark; Cuthbert, Joe; Petutschnigg, Johannes; Heymans, Stephane; Staessen, Jan A; Pieske, Burkert; Edelman, Frank; Clark, Andrew L; Díez, Javier; González, Arantxa; Rossignol, Patrick; Cleland, John G; Zannad, Faiez

Sex- and age-based differences in the natural history and outcome of dilated cardiomyopathy. (2018) Halliday, Brian P; Gulati, Ankur; Ali, Aamir; Newsome, Simon; Lota, Amrit; Tayal, Upasana; Vassiliou, Vassilios S; Arzanauskaite, Monika; Izgi, Cemil; Krishnathasan, Kaushiga; Singhal, Arvind; Chiew, Kayla; Gregson, John; Frenneaux, Michael P; Cook, Stuart A; Pennell, Dudley J; Collins, Peter; Cleland, John GF; Prasad, Sanjay K

Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial. (2017) Olivier, A; Pitt, B; Girerd, N; Lamiral, Z; Machu, JL; McMurray, JJ; Swedberg, K; van Veldhuisen, DJ; Collier, TJ; Pocock, SJ; Rossignol, P; Zannad, F; Pizard, A

Concentration-dependent clinical and prognostic importance of high-sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR-Reduced trial. (2021) Packer, Milton; Januzzi, James L; Ferreira, Joao Pedro; Anker, Stefan D; Butler, Javed; Filippatos, Gerasimos; Pocock, Stuart J; Brueckmann, Martina; Jamal, Waheed; Cotton, Daniel; Iwata, Tomoko; Zannad, Faiez; EMPEROR-Reduced Trial Committees and Investigators

Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial. (2021) Packer, Milton; Zannad, Faiez; Butler, Javed; Filippatos, Gerasimos; Ferreira, Joao Pedro; Pocock, Stuart J; Brueckmann, Martina; Zeller, Cordula; Hauske, Sibylle; Anker, Stefan D; EMPEROR-Preserved Trial Study Group

Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. (2020) Pellicori, Pierpaolo; Ferreira, João Pedro; Mariottoni, Beatrice; Brunner-La Rocca, Hans-Peter; Ahmed, Fozia Z; Verdonschot, Job; Collier, Tim; Cuthbert, Joe J; Petutschnigg, Johannes; Mujaj, Blerim; Girerd, Nicolas; González, Arantxa; Clark, Andrew L; Cosmi, Franco; Staessen, Jan A; Heymans, Stephane; Latini, Roberto; Rossignol, Patrick; Zannad, Faiez; Cleland, John GF

The win ratio method in heart failure trials: lessons learnt from EMPULSE. (2023) Pocock, Stuart J; Ferreira, João Pedro; Collier, Timothy J; Angermann, Christiane E; Biegus, Jan; Collins, Sean P; Kosiborod, Mikhail; Nassif, Michael E; Ponikowski, Piotr; Psotka, Mitchell A; Teerlink, John R; Tromp, Jasper; Gregson, John; Blatchford, Jonathan P; Zeller, Cordula; Voors, Adriaan A

Cardiovascular risk associated with serum potassium in the context of mineralocorticoid receptor antagonist use in patients with heart failure and left ventricular dysfunction. (2020) Rossignol, Patrick; Duarte, Kevin; Girerd, Nicolas; Karoui, Moez; McMurray, John JV; Swedberg, Karl; van Veldhuisen, Dirk J; Pocock, Stuart; Dickstein, Kenneth; Zannad, Faiez; Pitt, Bertram description

Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure. (2017) Wolsk, Emil; Claggett, Brian; Køber, Lars; Pocock, Stuart; Yusuf, Salim; Swedberg, Karl; McMurray, John JV; Granger, Christopher B; Pfeffer, Marc A; Solomon, Scott D

Restricted

Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced. (2022) Anker, Stefan D; Khan, Muhammad Shahzeb; Butler, Javed; Ofstad, Anne Pernille; Peil, Barbara; Pfarr, Egon; Doehner, Wolfram; Sattar, Naveed; Coats, Andrew JS; Filippatos, Gerasimos; Ferreira, João Pedro; Zannad, Faiez; Pocock, Stuart; Packer, Milton picture_as_pdf